Google DeepMind CEO Discusses Using AI to Revolutionize Drug Discovery

At Google I/O 2026, Demis Hassabis, CEO of Google DeepMind, stated the company's goal is to reimagine drug discovery using AI with the long-term aim of solving all diseases. The announcement focused on Gemini for Science, a set of experimental tools designed to aid researchers in making new discoveries.

By Victoria Song · The Verge · May 20, 2026, 21:06 UTC

Google DeepMind CEO Discusses Using AI to Revolutionize Drug Discovery

Tickers: $GOOGL

Topics: AI drug discovery Google DeepMind healthcare science communication

Read the full article at The Verge

More Technology news

Lego's BrickLink Marketplace Offline Following Unusual Activity The Verge · November 12, 2026, 14:13 UTC
TSMC Reports Unauthorized Leak of Current and Former Employee Data Seeking Alpha · November 12, 2026, 14:10 UTC
Fairphone Expands US Presence via Boost Mobile Carrier Partnership The Verge · November 12, 2026, 14:00 UTC
Google Agrees to Stricter Data Usage Terms Following Union Intervention Over Spirit Airlines Dataset The Verge · November 12, 2026, 12:19 UTC
Blackmagic Design Announces Ambisonic USB-C Microphone for Spatial Audio The Verge · November 12, 2026, 11:55 UTC
IBM and Quantinuum Compete via Divergent Quantum Computing Strategies Motley Fool · November 12, 2026, 09:14 UTC
Security Firm Reports Data Leak Involving SpaceXSI's Grok Build Coding Agent The Verge · November 11, 2026, 20:54 UTC
Google Labs Launches Tabletop, an Experimental AI Tool for Custom Collaborative Planning The Verge · November 11, 2026, 16:00 UTC
NBCUniversal Tests Conversational AI Search and Vertical Video Features for Peacock The Verge · November 11, 2026, 16:00 UTC
Google DeepMind Unveils AlphaGenome 2 to Predict Cellular Effects of DNA Mutations The Verge · November 11, 2026, 15:00 UTC